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Since its inception more than four decades ago, the Mitochondrial Free Radical Theory of Aging (MFRTA) has
served as a touchstone for research into the biology of aging. The MFRTA suggests that oxidative damage to
cellular macromolecules caused by reactive oxygen species (ROS) originating from mitochondria accumulates in
cells over an animal’s lifespan and eventually leads to the dysfunction and failure that characterizes aging. A central
prediction of the theory is that the ability to ameliorate or slow this process should be associated with a slowed
rate of aging and thus increased lifespan. A vast pool of data bearing on this idea has now been published. ROS
production, ROS neutralization and macromolecule repair have all been extensively studied in the context of
longevity. We review experimental evidence from comparisons between naturally long- or short-lived animal
species, from calorie restricted animals, and from genetically modified animals and weigh the strength of results
supporting the MFRTA. Viewed as a whole, the data accumulated from these studies have too often failed to
support the theory. Excellent, well controlled studies from the past decade in particular have isolated ROS as an
experimental variable and have shown no relationship between its production or neutralization and aging or
longevity. Instead, a role for mitochondrial ROS as intracellular messengers involved in the regulation of some basic
cellular processes, such as proliferation, differentiation and death, has emerged. If mitochondrial ROS are involved in
the aging process, it seems very likely it will be via highly specific and regulated cellular processes and not through
indiscriminate oxidative damage to macromolecules.Introduction
The basis for the mitochondrial free radical theory of
aging (MFRTA) was provided by Denham Harman [1,2],
who recognized the possibility of a connection between
mitochondrial oxidative phosphorylation, oxygen free
radical formation, cellular damage and the general de-
generative phenotype of aging. This theory continued to
grow and gain acceptance and by the beginning of the
next decade was suggested to be perhaps the major
underlying cause of aging [3]. Originally envisioned as a
collection of free radical processes that had their sources
and primary targets within mitochondria, the theory had
by 1981 grown to encompass non-mitochondrial targets
and phenomena, including amyloid plaques in the brain
and cancer. By the 21st century, the basic ideas espoused
in the MFRTA had grown to include a vast array of con-
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unless otherwise stated.and age-related phenomena in most cell types, tissues
and physiological processes (for example, [4-7]). Now
into its fifth decade, the MFRTA has provided the basic
framework for thousands of studies in the field of aging
that have linked mitochondrial free radical production
to cellular deficits associated with aging. As the number
of publications that address the MFRTA at some level
has grown, the theory has inevitably shown signs of falli-
bility, if not evidence of an outright midlife crisis. This
situation arises in part as a result of the wealth of new
information and our continually developing understand-
ing of mitochondrial oxygen free radical metabolism,
mitochondrial repair and turnover, and macromolecular
repair processes elsewhere in the cells that were unavail-
able when the theory was first postulated. In this review,
we present several key predictions arising from the
MFRTA that have now been comprehensively tested and
summarize these experimental results. We then briefly
present a more refined view of mitochondrial ROS as
participants in intracellular redox regulated processestd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Review
Predictions based on the MFRTA
The modern version of the MFRTA proposes that the pro-
genitor reactive oxygen species (ROS) superoxide (O2
·-)
originating from several mitochondrial enzymes, including
respiratory complexes I, II and III [8] enters into a number
of secondary reactions leading to other ROS that ul-
timately react with and indiscriminately damage cellular
macromolecular structures. The affected cells accumulate
such damage over time and will eventually cease to func-
tion normally, contributing to reduced physiological func-
tion, and ultimately process failure and death of the
organism. The MFRTA has been an excellent theory in
that it is founded on some real chemical considerations
and biological observations (for example, [9]) and is read-
ily testable.
If the MFRTA is correct, it logically follows that the
ability to prevent or slow the process of oxidative dam-
age accumulation should be associated with reduced
rates of age-related tissue dysfunction and, therefore, in-
creased lifespan. Testable hypotheses bearing on this
specific idea include: (1) that the rate of mitochondrial
ROS production should be reduced in longer-lived or-
ganisms, and interventions that reduce this rate should
extend lifespan; (2) that the cellular capacity to
neutralize ROS produced by mitochondria should be
greater in longer-lived organisms and interventions that
change this should affect lifespan; (3) that the capacity
to prevent, repair, remove or tolerate macromolecule
damage should be greater in longer-lived organisms and
interventions that alter these processes should affect
lifespan.
These three predictions of the MFRTA have been eval-
uated at length through decades of research. Although
there is insufficient space here to review all of the pub-
lished results, we discuss some key results and briefly
summarize the work in this area. We suggest that data
gleaned from inter-species comparisons, dietary manipu-
lations and genetic manipulations have collectively failed
to offer sufficient support for the MFRTA, and have thus
cast significant doubt on the validity of the theory.
While the field has not succeeded in validating the ori-
ginal MFRTA, it has, perhaps more importantly, contrib-
uted to an evolving appreciation of the roles of ROS
within animal cells extending well beyond macromol-
ecule damage. This more comprehensive view of ROS
includes their ability to participate in diverse signaling
pathways that directly impact cell behaviors, such as
proliferation, differentiation and death. In turn, these
specific processes probably do contribute to organism
aging and longevity, though in a far more nuanced waythat demands considering the signaling-based effects of
mitochondrial ROS on specific cellular processes. We
conclude the review by highlighting the emerging roles
of ROS as conveyors of information within animal cells.
The role of oxygen in the MFRTA
O2 plays a major role in the MFRTA (see [10] for a re-
view of hyperoxia and ROS), since it is one of two sub-
strates in the reaction(s) leading to O2
·- production (the
other being the electron donor, which can be a variety of
molecules; see Figure 1). Turrens et al. [11] demon-
strated the predicted linear relationship between O2
levels and the apparent rate of O2
·- production in submi-
tochondrial particles. One would, therefore, predict that
increased tissue O2 levels should be associated with in-
creased rates of O2
·- and more rapid tissue aging, as was
hypothesized by Harman [2]. Mammals have a sophisti-
cated circulatory system with hemoglobin that shields
most of their somatic cells from relatively high (approxi-
mately 21%) atmospheric O2, and maintains in most tis-
sues an internal milieu closer to 3% O2 (see [12] for
review). Therefore, it is not straightforward to vary en-
vironmental O2 levels and observe a concomitant effect
on tissue O2 levels in mammalian species. However, tiny
organisms like Caenorhabditis elegans (approximately
1 mm) that have been widely used to study the MFRTA
lack both a circulatory system and hemoglobin, so O2
simply diffuses to the sites of its use within the animal.
All C. elegans cells should, therefore, experience a tissue
O2 environment that is more directly connected to that
of the immediate environment. Although this species is
sometimes said to inhabit hypoxic environments, it is
flexible enough to flourish in normal atmosphere (21%
O2; [13]).
Honda et al. [14] investigated the relationship between
environmental O2 levels and lifespan, and found no ef-
fect when environmental O2 was maintained at set
values between 2% and 40% over the entire lifespan.
Yanase and Ishii [15] similarly found that daily exposure
to 90% O2 did not affect lifespan in wildtype C. elegans
and actually extended it in some strains. One explan-
ation for the apparent lack of correlation between O2
and lifespan in C. elegans is that the organism responds
by increasing its antioxidant capacity. However, in the
strains in which high O2 extended longevity, there was
no evidence of an up-regulation of any of the superoxide
dismutases in response to hyperoxia exposure [15]. Simi-
larly, genetic overexpression of these enzymes is not as-
sociated with increased lifespan [16]. A second possible
explanation might be that, at higher O2 levels when
mitochondrial ROS production might be problematic,
metabolism is redirected toward glucose fermentation.
However, Van Voorhies and Ward [17] showed that





















































































Figure 1 Mitochondrial ROS generation, neutralization, macromolecular damage and repair. A. Superoxide (O2
•-) is generated in the
mitochondrial matrix or inner membrane space (IMS) when an electron is donated to O2 (shown for complex I and III here). Superoxide produced
in the IMS is converted to H2O2 by Cu/Zn superoxide dismutase (CuZnSOD). Superoxide produced in the matrix is converted to H2O2 by Mn
superoxide dismustase (MnSOD). H2O2 can be neutralized to H2O through the action of the glutathione peroxidase (GPX)/glutathione reductase
(GR) cycle at the expense of reducing equivalents (NADPH) (reduced glutathione = GSH; oxidized glutathione = GSSG). H2O2 may also be
converted to H2O by peroxiredoxin (Prx), coupled to the oxidation of reduced thioredoxin (Trx). Oxidized Trx is reduced by thioredoxin reductase
(TrxR) at the expense of reducing equivalents (nicotinamide adenine dinucleotide phosphate, NADPH). H2O2 can also diffuse into the cytosol,
where it is neutralized to H2O by catalase (CAT) or other cytosolic enzymes (not shown). Superoxide in the matrix or IMS can form other ROS,
such as peroxynitrite (ONOO-). H2O2 may also form other ROS, such as hydroxyl radicals (•OH). B. ROS produced by mitochondria can damage
nuclear and mitochondrial DNA, causing lesions, including base modifications. These effects are countered by a variety of DNA repair processes,
including the base excision repair pathway. C. ROS generated by mitochondria may damage cytosolic proteins. Heat shock proteins (Hsps)
interact with misfolded proteins and assist in returning proteins to their native structure. Alternatively, damaged proteins can be ubiquitinated
(Ub) and degraded by proteasomes. D. ROS generated by mitochondria can damage membrane phospholipid fatty acids via peroxidation
reactions. Note that, for the purpose of clarity, this figure omits and/or simplifies some pathways involved in mitochondrial ROS metabolism.
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reorganization occurs to favor glucose fermentation when
high environmental O2 levels might make oxidative phos-
phorylation dangerous appears also to be invalid. There-
fore, higher levels of environmental O2, which should
translate directly into higher O2 levels within the organism
and therefore higher rates of O2
·- production in cells (if in-
deed antioxidant enzymes are not broadly induced), did
not affect longevity in C. elegans.
Within some organisms (for example, humans) there
are major differences in the relative exposure to O2 of
somatic cells in different tissues. For example, some of
the highest levels of O2 exposure in mammals occur in
the lungs (approximately 10 to 14%), and one might
therefore predict that lung epithelium should be particu-
larly vulnerable to the degenerative effects of aging, es-
pecially compared to tissues like cartilage, in which
chondrocytes exist in a relatively hypoxic environment
(<3% O2). However, there is no evidence that this is so.
Both Type I lung alveolar epithelial cells and articular
chondrocytes have a similar mitochondrial volume dens-
ity (that is, 3 to 5% [18]), suggesting similar rates of ATP
turnover and O2 consumption, and therefore presumably
also O2
·- production, yet there is no evidence that these
different cell types age at different rates despite the fact
that they exist in internal environments with drastically
different O2 levels.
Within an organism, there is also a broad range of
mitochondrial abundance in different cell types, ranging
from 3 to 5% volume density in chondrocytes to 22 to
37% (depending upon species) in cardiomyocytes [19].
Harman [2] recognized that relative mitochondrial abun-
dance might contribute to rates of cellular ROS produc-
tion, though he considered it in the context of inter-
species allometric scaling of metabolism. If ROS origin-
ating from mitochondria are responsible for aging then
one would also predict that, since there should be more
ROS produced within cardiomyocytes than in chondro-
cytes, the heart would age more rapidly (superoxide dis-
mutase levels are similar in heart and cartilage [20]).
While it is surely difficult to quantify relative rates of
tissue aging within an organism, a recent epigenetic
method for doing just this [21] suggests that heart tissue
is actually typified by a particularly slow aging rate.
The basic differences in mitochondrial volume density
(within a specific cell type) that exist among animal spe-
cies are also inconsistent with a straightforward relation-
ship between mitochondrial abundance and longevity.
Some of the longest-lived endothermic vertebrate spe-
cies for their respective body masses are birds and bats,
even though both clades are generally characterized by
relatively high mass-specific metabolic rates, and high
mitochondrial abundance in heart and skeletal muscle
tissues (see Robb et al. [22] for review).In summary, the predicted relationships between ei-
ther O2 and aging rate or mitochondrial abundance
within cells and aging rate have not been reliably identi-
fied. It is straightforward to identify potential reasons for
this lack of correlation: reduced rate of ROS production,
increased ROS neutralization capacity, or superior oxi-
dative damage repair are all possible explanations. All of
these possibilities are discussed below.
Reactive oxygen species production
Based on the above examples, it seems that the pre-
dicted simple relationships among O2 exposure, mito-
chondrial abundance and aging/longevity do not exist.
One explanation for this might be that long-lived and/or
high metabolic rate species have adapted to reduce the
rate at which their mitochondria produce ROS. This hy-
pothesis has been tested in many studies (see Table 1 for
some examples). Sanz et al. [23] compared the net rates
of H2O2 production in isolated mitochondria (whole
flies) from three strains of Drosophila melanogaster with
maximum lifespans ranging from 49 to 91 days, and
found limited evidence for an association with lifespan.
Measurements of mitochondrial H2O2 production by
isolated vascular tissues of the extremely long-lived
naked mole rats and Damara mole rats also failed to un-
cover differences compared to shorter-lived guinea pigs
and mice [24]. Similarly, mitochondrial H2O2 production
of isolated vascular tissue from the extremely long lived
naked mole rats and Damara mole rats was found to be
about the same as in shorter-lived guinea pigs and mice
[24]. A similar absence of association between H2O2
generation was noted in comparisons of isolated heart
mitochondria respiring on succinate (+/− the respiratory
complex I inhibitor rotenone) between naked mole rats
and mice [25], though in the same experiment Damara
mole rat heart mitochondria did have lower H2O2 pro-
duction rates than guinea pig (only in the absence of
rotenone [25]). These authors also compared rates of
heart mitochondrial H2O2 production in the long-lived
domestic pigeon (Columba livia), the shorter-lived
Japanese quail Coturnix japonica and laboratory rats. H2O2
production rates during succinate oxidation are indeed
lower than in the laboratory rat, but only in the absence
of rotenone. However, rates in Japanese quail were sig-
nificantly higher than those in rats, despite the fact that
these two species have similar maximum lifespans
(MLSPs). In a similar comparison between the long-
lived house sparrow Passer domesticus and laboratory
mice, the rates of isolated liver mitochondrial H2O2 pro-
duction were significantly greater in the longer-lived
species [26]. When these data are expressed as the pro-
portion of total oxygen consumed that was converted
into H2O2, no between species differences are evident.
Montgomery et al. [27] also failed to find differences in
Table 1 Hydrogen peroxide production by isolated mitochondria or tissue of relatively short- and long-lived animal
species
Species investigated Tissue Metabolic substrate(s) used Relationship to MLSP* Reference
Fruit fly Drosophila melanogaster Whole body Pyruvate + proline Weak correlation [23]
Glycerol-3-phosphate Weak correlation males only
Glycerol-3-phosphate + rotenone No correlation
Naked mole rat Heterocephalus
glaber, Damara mole rat
Cryptomas damarensis, Guinea
pig Cavia porcellus, laboratory
mouse Mus musculus
Vascular tissue Succinate ± rotenone No correlation [24]
Domestic pigeon Columba livia,
Japanese quail Coturnix japonica,
laboratory rat Rattus norvegicus
Isolated heart mitochondria Succinate Negative correlation [25]
Succinate + rotenone No correlation
Laboratory mouse Mus musculus,
house sparrow Passer domesticus
Isolated liver mitochondria Glutamate +malate No correlation when standardized to
total O2 consumption
[26]
Laboratory mouse Mus musculus,




Multiple substrates No correlation when O2
consumption rates considered
[28]
Pigeon (species not indicated),
rat (Rattus norvegicus)
Isolated mitochondria from
heart, muscle and liver
Pyruvate +malate Higher rates in pigeon muscle [27]
Succinate Higher rates in rat heart
Succinate + rotenone Higher rates in rat heart






Not given No correlation [29]
Little brown bat Myotis lucifugus,
laboratory mouse Mus musculus
Isolated liver mitochondria Glutamate +malate Negative correlation [26]
12 mammalian and avian species Isolated heart mitochondria Succinate Negative correlation [25]
Succinate + rotenone No correlation
No correlationPyruvate +malate ± rotentone
*MLSP =Maximum Lifespan.
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tion between rats and pigeons respiring on several com-
binations of respiratory substrates. Indeed, these authors
found that the direction of rat versus pigeon differences
depended on tissue: pigeon H2O2 production rates were
greater in skeletal muscle, but lower in heart muscle (re-
spiring on succinate or succinate + rotenone). Kuzmiak
et al. [28] also found virtually no differences in isolated
skeletal muscle H2O2 production between sparrows and
mice using various combinations of metabolic fuels
(pyruvate, malate, glutamate and glycerol-3-phosphate).
Brunet-Rossinni [29] found no consistent association be-
tween MLSP and the rates of H2O2 production in mito-
chondria isolated from brain, heart and kidney of the
little brown bat Myotis lucifugus (MLSP = 34 y), the
white-footed mouse Peromyscus leucopus (MLSP = 8 y)
and the short-tailed shrew Blarina brevicauda (MLSP =
2 y). On the other hand, Brown et al. [26] showed that
liver mitochondria from the little brown bat produced
H2O2 at lower rates than laboratory mice when respiring
on glutamate +malate. The largest and most complete
single test of this hypothesis has been published byLambert et al. [25] and included isolated heart mito-
chondria from 12 mammal and bird species. Under most
experimental conditions, these investigators found few
differences in H2O2 production rates between species
and no association with MLSP. Only the rate of H2O2
production in mitochondria oxidizing succinate alone
was correlated negatively with MLSP. Taken together,
however, the collection of experimental results discussed
above provides little support for the hypothesis that
longer-lived organisms have adapted to produce less
mitochondrial ROS (but see below for a discussion re-
garding the limitations of these experimental data).
Another experimental model of reduced aging rate
and increased longevity is caloric restriction, which has
been used extensively to study mitochondrial ROS pro-
duction. Caloric restriction often extends maximum life-
span in mice and rats, though the magnitude of the
effect appears highly dependent upon strain and experi-
mental conditions (see [30] for review). In many studies
reduced rates of mitochondrial ROS production associ-
ated with caloric restriction have been reported, though
there is evidence that this outcome is highly variable.
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mitochondrial ROS production data from calorie restric-
tion studies done with mice and rats. Perhaps surpris-
ingly, in all tissues examined, including brain, heart,
kidney, liver and skeletal muscle, the absence of effect
on mitochondrial ROS production occurred almost as
often as caloric restriction reduced rates of ROS produc-
tion. This absence of a consistent effect is notable par-
ticularly given that positive results are more likely to be
published than negative outcomes in these types of stud-
ies (for example, see [30]). We, therefore, conclude that
the caloric restriction studies, as a whole, do not offer
strong support for the prediction of the MFRTA that
mitochondrial ROS production will be reduced.
Although the data outlined above are inconsistent with
the hypothesis that a reduced aging rate is associated
with reduced rates of mitochondrial ROS production, an
important caveat regarding all of these data concerns
how ROS production has been measured. Assumptions
based on ROS measurements obtained from isolated
mitochondria respiring on saturating concentrations of a
single fuel in buffer equilibrated to atmospheric oxygen
have limited physiological relevance. These limitations of
the experimental conditions under which virtually all of
our existing data have been collected have been well de-
scribed (for example, see Robb et al. [22] for review),
and are sufficiently significant that it is impossible to
make strong conclusions at present. The ongoing devel-
opment of in situ ROS probes will be important in gen-
erating more physiologically relevant data in intact cells
(for example, [32]).
Another important point worth considering is that,
though mitochondria may be the primary source of ROS
in some cell types (particularly those with high mito-
chondrial abundance, though more experimental evi-
dence is needed for this), alternate sources of ROS are
clearly more important in others. For example, NADPH
oxidase is a major source of ROS in activated leukocytes;
peroxisomes appear to make more significant contribu-
tions to overall ROS production in liver. Brown and
Borutaite [33] recently published a thoughtful criticism
of what has become a dogma, that is, that mitochondria
are the major source of ROS in most cells. As these au-
thors point out, there is, in fact, only a handful of studies
in which the relative contributions of various cellular
sources of ROS have been quantified such that this
statement can be evidence based. Even where they have
been, saturating concentrations of non-physiological
substrate combinations have been used and the mea-
surements done in atmosphere-saturated buffers. Since
some ROS-producing enzymes like NADPH oxidase and
xanthine oxidase have relatively high Km(O2), the ele-
vated O2 levels under which the measurements have
been made are likely to exaggerate the contributions ofthese enzymes to overall ROS production. Overall, there
are virtually no data that directly bears on the contribu-
tion of mitochondrial ROS production to overall rates in
mammalian (or other animal species) tissues under con-
ditions that adequately approximate physiological.
Recently, several investigators have also proposed
alternative views of the role of mitochondria in the
MFRTA. Brown and Borutaite [33] and Hickey et al.
[34] suggest that, since mitochondria are capable of con-
suming ROS via their constituent antioxidant enzymes
and cytochrome c/cytochrome c oxidase, the role of
mitochondria under some physiological conditions could
be as a ROS sink, rather than a source. Other investiga-
tors (for example, [35]) have suggested the hypothesis
that mitochondrial ROS provides a beneficial hormetic
stimulus that could enhance cellular resistance to oxida-
tive stress by promoting the up-regulation of defense
mechanisms. These interesting hypotheses, even if
proven correct, would nonetheless be inconsistent with
the MFRTA. Therefore, with the evidence accumulated
to date using the variety of experimental approaches dis-
cussed above, the hypothesis that longevity should be asso-
ciated with reductions in mitochondrial ROS production
is not supported.Antioxidants
The second prediction arising from the MFRTA is that
greater longevity should be associated with a greater
capacity to neutralize mitochondrial ROS (Figure 1).
Within the mitochondrial matrix Mn O2
·- dismutase
(MnSOD) catalyzes the conversion of O2
·- to H2O2 in a
diffusion-rate limited reaction [36,37]. The inner mem-
brane is impermeable to O2
·- due to this molecule’s
negative charge, and as the sole O2
·- dismutase in the
matrix MnSOD therefore acts as a primary regulator of
O2
·- concentration in this compartment and is important
in controlling concentrations of ROS generated from
O2
·- produced by mitochondria. O2
·- produced on the
IMS side of the electron transport chain is converted to
H2O2 by CuZnSOD, a primarily cytosolic antioxidant
enzyme that has also been associated with the IMS. In
rat liver, nearly 3% of the total cellular concentration of
this enzyme is localized to the mitochondrial IMS [38].
H2O2 generated by O2
·- dismutation in the matrix may
go on to be further detoxified to water within mitochon-
dria by glutathione peroxidase (reviewed by Margis et al.
[39]), peroxiredoxin 3 and 5 [40], and thioredoxin path-
ways [41] or, in heart mitochondria, catalase [42]. Mito-
chondrial H2O2 that is not intercepted by antioxidant
enzymes in the matrix can diffuse into the cytosol, where
it may be detoxified by cytosolic isozymes in the gluta-
thione [39] and thioredoxin [43] pathways, or by the en-
zyme catalase [44].
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·- dismutases of the
mitochondrial (MnSOD) and cytosolic (CuZnSOD)
compartments and several enzymes involved in H2O2
neutralization (catalase and also the cycle of glutathione
oxidation involving glutathione peroxidase and glutathi-
one reductase) have been made in many of the same ex-
perimental models used for assessing mitochondrial
ROS production. In a comparison of the naked mole rat
and laboratory mouse, activities of MnSOD (not cor-
rected for mitochondrial abundance) and CuZnSOD
measured in liver at mid-age are significantly higher in
the naked mole rat [45]. In contrast, catalase activities
are not different and glutathione peroxidase activities
are an order of magnitude lower in the naked mole rat
liver. Page et al. [46] measured all five of the antioxidant
enzymes listed above in brain, heart and liver tissues of
14 species of endotherm vertebrates. Of 15 tested corre-
lations (five enzymes x three tissues), only two were
positive and statistically significant. These were MnSOD
and catalase in the brain, which were higher in longer-
lived species, even after correction for body mass and
phylogenetic effects [46]. Similar measurements of two
other antioxidant enzymes, glutaredoxin and thioredoxin
reductase, also failed to reveal significant positive corre-
lations with lifespan in any of these three tissues [47].
Thus, of 21 tested associations of six antioxidant en-
zymes only 2 showed the hypothesized positive correla-
tions with lifespan [46,48]. Since measurements made in
whole tissue homogenates provide little insight into ROS
neutralization within mitochondria, we measured gluta-
thione peroxidase and glutathione reductase activities in
brain mitochondria isolated from eight species of verte-
brate endotherm (Robb et al. [22]). This analysis also
failed to show a relationship between with MLSP, and
therefore failed to support the second hypothesis relat-
ing to the MFRTA, that is, that the cellular capacity
to neutralize ROS should be greater in longer-lived
organisms.
Walsh et al. [31] recently summarized the results of sev-
eral decades of studies examining antioxidant enzyme
levels/activities (superoxide dismutases, catalase, gluta-
thione metabolizing enzymes) in the context of caloric
restriction. Similar to their findings with respect to mito-
chondrial ROS production, these authors show the absence
of a consistent up-regulation of antioxidant enzymes con-
comitant with caloric restriction in mice and rats.
A number of mammalian lifespan studies have been
conducted utilizing transgenic or knockout laboratory
mouse models to increase or decrease gene expression
of mitochondrial and other key intracellular antioxidant
enzymes (Table 2). The results of such studies have been
the in-depth focus of other review papers (see [49-51])
and, therefore, will not be reviewed in detail here. Over-
whelmingly, the conclusions from these studies has beenthat, although the expected increases and decreases in
tissue oxidative damage biomarkers are usually observed
in antioxidant enzyme gene under-expressing and over-
expressing individuals, respectively, there are seldom
corresponding effects on longevity. Thus, the results of
experiments using this approach have most often yielded
results that are inconsistent with the MFRTA.
One exception to this general rule has been the targeting
of human catalase to mitochondria in mice, which does
appear to increase both mean and maximum lifespan, al-
though the effect on lifespan was apparently reduced when
the transgenic mice were backcrossed to control for differ-
ences in genetic background [56]. Interpretation of this ex-
perimental model from the perspective of mitochondrial
ROS and intracellular oxidative damage leading to aging
and tissue dysfunction (reviewed in Wanagat et al. [62]) is
complicated by the fact that human catalase expression in
these mouse tissues is mosaic, with the human protein be-
ing detectable in only 10 to 50% of all cells ([56], and un-
published results from skeletal muscle). Although the
authors do not provide an average number of transgene
expressing cells we can assume that less than 50% either
do not express the transgene or express it at very low
levels that are not detectable. By extension, intracellu-
lar macromolecules within the majority of cells would
presumably not have enhanced protection from mito-
chondrial ROS. The observed effects of the genetic ma-
nipulation on aging and age-related pathologies
(Wanagat et al. [62]) must presumably originate from a
subset of cells within the mouse tissues, and for this
reason it is difficult to interpret what is happening in
this experimental model strictly from the perspective of
the MFRTA.
Small molecule antioxidants have been promoted exten-
sively to the general public as anti-aging and pro-longevity
supplements. The evidentiary underpinnings of this are
rooted in part in the observations of pro-health effects of
various plant-based foods with antioxidant constituents.
Hundreds of experiments have now been completed
to examine the putative anti-aging effects of vitamin E
(tocopherols and tocotrienols) in a diverse range of species
from protists to mammals, and the results of these experi-
ments have been reviewed recently [63]. Vitamin E has
variously been shown to have no effect, a positive effect
and even a negative effect on aging/lifespan. Certainly, no
clear picture of an anti-aging activity emerges in the hun-
dreds of studies that have been conducted. This includes
human studies, some of which have been terminated pre-
maturely due to adverse outcomes (see [63] for review). A
similar lack of consensus has emerged with respect to the
anti-aging effects of a number of other vitamin antioxidant
supplements, after many hundreds of experimental
studies and clinical trials (for example, see the review by
Dolora et al. 2012 [64]).
Table 2 Survival data for mice over-expressing or under-expressing antioxidant enzymes
Genotype Strain N$ 90th percentile survival (95% C.I.) [versus WT Control] Survivorship effect? (P >0.05) Reference
Single gene manipulations:
Mn superoxide dismutase
Sod2 Tg C57BL/6 (males) 50 1,165 d (1,092 to 1,245) [versus 1,128 d (1,080 to 1,206)] No [49]
Sod2 Tg Not indicated 24 N/A - 43.0 months [versus 36.5 months] and N/A* [52]
Sod2+/− C57BL/6 (females) 70 1,027 d (1,044 to 1,154) [versus 1,034 d (1,002 to 1,099)] No [53]
CuZn superoxide dismutase
Sod1 Tg C57BL/6 (male) 44 1,121 d [versus 1,090 d] No [50]
Sod1 Tg (homozygous) CD1 119 30 months [versus 31 months]! No [54]
Sod1 Tg (hemizygous) CD1 200 31 months [versus 31 months]! No [54]
Sod1−/− C57BL/6 10 762 d (761 to 767) [versus 1,076 d (1,035 to 1,298)] Yes - decrease in mean lifespan [51]
Sod1+/− C57BL/6 12 N/A - 28.7 ± 1.3 months [versus 29.8 ± 2.1 months]^ No [55]
Sod1−/− C57BL/6 18 N/A - 20.8 ± 0.7 months [versus 29.8 ± 2.1 monthsC1]^ Yes [55]
Catalase
Cat Tg C57BL/6 (male) 44 1,099 d [versus 1,090 d] No [50]
Cat Tgp C57BL/6 < 44 N/A (only a survivor curve was given - clear values not
provided)
No’ [56]
Cat Tgm C57BL/6 < 62 N/A Yes - increased median and maximum
lifespan
[56]
Cat Tgn C57BL/6 < 78 N/A No [56]
Glutathione peroxidase 4
Gpx4 Tg C57BL/6 (males) 18 1,072 d (1,062 to 1,080) [versus 1,106 d (1,026 to 1,161)] No [51]




Gpx1−/− C57BL/6 (females) 59 1,063 d (1,031 to 1,183) [versus 1,091 d (1,040 to 1,188)] No [58]
Thioredoxin 1
Trx1 Tg C57BL/6 (males)> 41 1,134 d [versus 1,159 d] No# [59]
Trx1 Tg C57BL/6 (males)> 60 1,151 d [versus 1,143 d] No# [59]
Trx1 Tg C57BL/6 (females) 40 1,152 d [versus 1,230 d] No [59]
Thioredoxin 2
Trx2+/− Mix of C57BL/6 J & 129
(females)

















Table 2 Survival data for mice over-expressing or under-expressing antioxidant enzymes (Continued)
Methionine sulfoxide
reductase
MsrA−/− Mix of C57BL/6 J & 129 (males) 25 1,157 d (1,105 to 1,203) [versus 1,140 d (1,092 to 1,204)]C2 No [60]
MsrA−/− C57BL/6 J 17 N/A - 409 ± 33 d [versus 680 ± 71 d]^ Yes - increase in mean lifespan [61]
MsrA+/− C57BL/6 J 8 N/A - 672 ± 80 d [versus 680 ± 71 d]^ No [61]
Multiple gene manipulations:
Sod1 Tg / Sod2 Tg C57BL/6 (males) 54 1,075 d [versus 1,090 d] No [50]
Sod1−/− / Sod2+/− C57BL/6 11 886 d (817 to 883) [versus 1,076 d (1,035 to 1,298)] Yes [51]
Sod1Tg / Cat Tg C57BL/6 (males) 47 1,098 d [versus 1,090 d] No [50]
Sod2+/− / Gpx4+/− C57BL/6 11 1,025 d (938 to 1,099) [versus 1,076 d (1,035 to 1,298)] No [51]
Sod2+/− / Gpx1+/− C57BL/6 25 1,057 d (1,027 to 1,298) [versus 1,091 d (1,040 to 1,188)] No [58]
Sod2+/−/Gpx1−/− C57BL/6 33 1,121 d (1,069 to 1,248) [versus 1,091 d (1,040 to 1,188)] No [58]
Sod1−/− / Gpx1−/− C57BL/6 (males) 11 828 d (799 to 868) [versus 1,076 d (1,035 to 1,298)] Yes - decrease in mean lifespan [51]
Sod1−/− / Gpx4+/− C57BL/6 (males) 16 866 d (817 to 883 [versus 1,076 d (1,035 to 1,298)] Yes - decrease in mean and median lifespan [51]
Gpx1-/ / Gpx4+/− C57BL/6 40 1,124 d (1,086 to 1,359) [versus 1,076 d (1,035 to 1,298)] No [51]
Tg = transgenic overexpression.
d = days.
$Sample size of genetically manipulated mice groups. Sample sizes were generally similar or identical to that of WT control groups, except in [31], where N = 119 for control group.
N/A = not available.
*Statistical analysis was not performed. Increased maximum lifespan was observed, but no changes in mean lifespan (Means: Sod2 Tg = 28.8 months versus WT = 27.6 months).
& Max lifespan (90th percentile survival was not provided).
!95th percentile survival.
^Mean lifespan ± SEM (90th percentile survival was not provided).
C1Control groups consisted of Sod1+/+ and Sod1+/− mice. Values are ± SEM.
PCatalase was targeted to the peroxisome.
mCatalase was targeted to mitochondria.
nCatalase was targeted to the nucleus.
<Two mouse lines were used.
`A slight significant extension of median lifespan was observed in one mouse line (and no extension of maximum lifespan).
>Two separate cohorts of mice were used in the study.
C2Control mice consisted of both WT and Msr+/− mice.
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phenolic stilbenes, such as resveratrol, have more recently
been put forth as anti-aging elixirs due in part to their
antioxidant activities. Although early results seemed to
suggest pro-longevity properties for resveratrol, the dozens
of experiments instigated by these findings failed to con-
firm any general positive effects. While there is some evi-
dence for increased lifespan in C. elegans, it is lacking in
most other species [65]. The National Institutes of Health’s
Aging Intervention Testing Study (http://www.nia.nih.gov/
research/dab/interventions-testing-program-itp/compounds-
testing) has investigated the pro-longevity properties of a
number of small molecule antioxidants, including vitamin
E and resveratrol, in mice and reported no beneficial ef-
fects on lifespan.
Based on the results discussed above, the evidence for
an association between small molecule antioxidant supple-
mentation and slowed aging and/or increased longevity is
insufficient to support the MFRTA. However, it is import-
ant to note that none of these tested molecules is specific-
ally targeted to mitochondria, so the extent to which they
access the organelle in any tissue or cell is likely highly
variable. To address this potential limitation, some investi-
gators have developed antioxidants conjugated to posi-
tively charged, membrane-permeant moieties that target
them specifically to mitochondria. Perhaps the best stud-
ied example is the mitochondria targeted ubiquinone
(MitoQ) [32]. The anti-aging properties of MitoQ have
been tested in D. melanogaster, where it failed to extend
lifespan [66]. While we await further evidence of the abil-
ity of MitoQ, or other mitochondria-targeted antioxidants,
to slow the rate of aging, at this time there is no compel-
ling evidence that reducing the rate of mitochondrial ROS
production will slow aging or increase lifespan. Therefore,
this line of investigation has failed to offer clear support
for the MFRTA [67].
Repair and removal of oxidative damage
In the context of the MFRTA, mitochondria generated
ROS have generally been considered with respect to the
damage they may cause cellular macromolecules. Cellular
aging may therefore be affected by the avoidance of such
damage, or by the repair or degradation of damaged cellu-
lar constituents (Figure 1). All of these predictions have
been tested, and quite an extensive collection of data has
accumulated over the past decade in particular. Only a
brief overview of the results of these investigations is pre-
sented below. It is important to acknowledge that many of
the avoidance, repair and removal activities/properties dis-
cussed below in the context of the MFRTA are also in-
volved in processes not related to oxidative damage and so
these results must be interpreted with this caveat in mind.
We tested the prediction that longer-lived organisms
might have superior protein recycling or stabilizationcapacities, thus allowing them to more rapidly clear or
refold, for example, oxidatively damaged proteins from
cells. Salway et al. [47] measured the activity of the 20S/
26S proteasome in tissues of 15 species of vertebrate en-
dotherms ranging in MLSP from a few years to several
decades and found no evidence of an association be-
tween longevity and proteasome activity. Interestingly,
however, the basal levels of several heat shock proteins
were found to correlate positively with longevity in the
same collection of species [48]. Thus, there is some evi-
dence that mechanisms to maintain protein homeostasis
might be superior in longer-lived animal species. It is
important to note, though, that this latter mechanism is
not specific to oxidatively damaged proteins and, indeed,
may be driven by entirely different selective pressures.
Experiments with calorie restricted rodents have pro-
duced varying results. In skeletal muscle, caloric restric-
tion has been shown to increase [68] and to decrease
[69] proteasome activity in older rats. In heart tissue of
rats, Li et al. [70] found different results of caloric re-
striction on 20S and 26S proteasome activities. In liver,
mild caloric restriction but not every other day feeding
increased some proteasome activities, but did not affect
others in aged rats [71]. Taken together, the results from
comparative studies and caloric restriction are somewhat
equivocal in their support for the prediction that repair
and removal of oxidatively damaged proteins will be
greater in longer-lived organisms. However, much more
work is needed before any strong conclusions can be
made.
Unsaturated phospholipids in mitochondrial and other
cellular membranes are vulnerable to oxidative damage
mediated by mitochondrial ROS. The hypothesis that re-
sistance of membrane phospholipids to peroxidative
damage is enhanced in longer-lived organisms has been
tested by investigators over the past two decades (see
[72] for review). Although there is some evidence to
support this hypothesis, it is not clear whether differ-
ences in peroxidizability index (that is, the propensity of
phospholipid species to undergo peroxidation reactions)
are related to lifespan or to other traits (see [73]).
DNA oxidative damage is thought to be a major cause
of aging (see [74] for review), with mitochondrial ROS
considered to be the origin of damaging ROS in this
equation. One of the major pathways for repairing oxi-
dative damage in both mitochondrial and nuclear DNA
is base excision repair (BER). (Page and Stuart [75])
measured nuclear BER enzyme activities in tissues of
mammals and birds with a range of MLSPs from several
years to several decades and found no evidence that they
were enhanced in longer-lived species. Knockout and
overexpression of BER genes in mice has similarly not
often had the predicted effects on lifespan. For example,
the OGG1 gene knockout mice with impaired ability to
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from mitochondrial DNA are without apparent aging
phenotype (Stuart et al. [76]). Similarly, the heterozy-
gous knockout of polymerase β, a major BER polymer-
ase, did not shorten maximum lifespan of mice [77].
With respect to the roles of DNA repair in longevity,
it is probably important to make a distinction between
the needs of post-mitotic somatic cells and those that
continue to divide throughout the lifespan. For example,
Page and Stuart [75] made measurements in nuclear
fractions from liver and brain tissue, which is composed
primarily of post-mitotic and highly oxidative cells. Park
et al. [78] and others [73] have provided evidence that
multiple DNA repair pathways, including BER, are en-
hanced in cultured fibroblasts established from longer-
lived versus short-lived mammals. Of course, in this cell
type, mitochondrial volume density is typically quite low
(approximately 3%), as is the reliance of oxidative phos-
phorylation to meet ATP turnover needs and, therefore,
mitochondrial ROS production should be moderate, par-
ticularly when the cells are grown at physiological con-
centrations of O2. In addition, as noted above, one
problem with interpreting DNA repair activities strictly
within the context of the MFRTA is that pathways such
as BER that are involved in repairing oxidative damage
also repair lesions that have no direct association with
ROS.
ROS as signaling molecules
Taken together, the results discussed above suggest that if
ROS participate in the biology of aging, it is not via the
straightforward processes envisioned by the MFRTA. Ra-
ther, oxidative modifications elicited by ROS appear to
alter protein biochemistry by affecting specific residues
within an enzyme’s active site, or within essential struc-
tural domains that participate in protein-protein or
protein-DNA interactions. Oxidative modifications of
specific cysteine residues are thought to be an essential
component of redox signaling systems (reviewed in
[79]). In all cases, the proximal environment of the
oxidation-sensitive residue, including its apparent pKa
and its exposure to the intracellular milieu, contributes
to the ease with which it is modified by ROS [80]. It is
these properties that can impart specificity in the oxida-
tive modification of proteins.
Mitochondrial ROS arise from a one-electron reduc-
tion of molecular oxygen by electron carriers and other
matrix enzymes to produce the superoxide anion. This
charged species is rapidly converted to H2O2 peroxide,
which, unlike its progenitor superoxide, is capable of dif-
fusing from mitochondria to the cytosol where it may
subsequently alter the activities of proteins that include
transcription factors and components of signaling path-
ways. Intracellular H2O2 concentrations are capable offluctuating on a rapid timescale in response to internal
and external cues. In addition, this particular species is
relatively inert to reaction with macromolecules, a prop-
erty that enables its diffusion in the cytosol and is consist-
ent with its proposed actions as a signaling molecule [80].
ROS have been shown to participate in directing the
cellular response under pathological conditions, includ-
ing hypoxia, inflammatory signals, starvation and ische-
mia reperfusion [79,81]. In the context of animal aging,
a trend towards a more oxidative environment with in-
creasing age (for example, Cocheme et al., [82]) may im-
pact the activities of a suite of signaling pathways
involved in regulating lifespan and in the development
of age-related disease. Beyond a function in signaling
under stress conditions, a putative role for ROS in the
proliferation and differentiation of animal cells has been
outlined on the basis of observations made following the
manipulation of ROS levels. Growth factors, such as
IGF-1, VEGF and EGF, stimulate ROS production that
inactivates tyrosine phosphatases, and in turn permits
the propagation of signaling pathways favoring growth
and division (reviewed in [83]). In contrast, overexpres-
sion of catalase or glutathione peroxidase (two enzymes
that detoxify H2O2) inhibits H2O2 and serum-stimulated
proliferation in endothelial cells (Ruiz-Gines et al. [84];
Faucher et al., [85]). In vivo, overexpression of a
mitochondria-targeted catalase in mice reduces the inci-
dence of breast cancer tumor formation in these animals,
data that provide tentative support of a potential role for
mitochondrial H2O2 production as a mitogenic signal
in vivo [86]. While these data could be used to build the
argument that a reduction in mitochondrial ROS produc-
tion reduces cancer in older populations, it is important to
note that overexpression of antioxidant enzymes that re-
duce intracellular ROS levels are not generally associated
with increased longevity, and that the roles of mitochon-
drial ROS are complex.
However, the effects of H2O2 on the cell cycle are not
completely straightforward, as altered intracellular H2O2
concentrations have also been reported to slow cell prolif-
eration. For example, manipulation of endogenous mito-
chondrial H2O2 production via alterations in MnSOD
levels has been shown to promote entry into quiescence
[87], and to slow proliferation in a number of cancerous
cell lines (for example, [88-90]). In human glioma cells the
concomitant overexpression of MnSOD and GPx abol-
ishes the growth inhibitory effects that are associated with
MnSOD overexpression alone, suggesting that in this cell
type the MnSOD-stimulated increase in H2O2 concentra-
tions underlies changes in proliferation [91]. Thus, H2O2
may act as a signal to stimulate or inhibit cell division.
A critical aspect of ROS signaling is its ability to act in
an autonomous, highly localized, largely cell-specific man-
ner. Recently, the potential regulatory actions of ROS have
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tissue resident stem cells. Stem cells reside in low oxygen
niches and are primarily glycolytic in their undifferentiated
state [92]. In Drosophila, hematopoietic progenitor cells
produce low basal levels of ROS, while an increase in ROS
in these cells triggers differentiation into mature blood cells
(Owusu-Ansah et al. [93]). Overexpression of H2O2 detoxi-
fying enzymes, including catalase, impedes hematopoietic
stem cell differentiation pathways and maintains stem cell
populations in a quiescent state [93]. In mammalian sys-
tems, high levels of ROS in hematopoietic stem cells are as-
sociated with depletion of stem cell populations due to
dysregulated p38 MAPK activity, an effect that can be cor-
rected with antioxidant treatment [94]. Differentiation of
human embryonic stem cells is accompanied by increased
mitochondrial mass, increased oxygen consumption and el-
evated ROS concentrations [95]. An important consider-
ation when evaluating the importance of ROS in stem cell
biology is the inherent difficulty in distinguishing between
ROS-specific effects and the dramatic metabolic changes
that occur generally during stem cell differentiation. Within
the context of the MFRTA, the ability of ROS to regulate
tissue-specific regenerative capacity could have important
implications in maintaining organ function and thus animal
health throughout the lifespan. However, currently there is
no experimental evidence with which to evaluate this idea.
The select examples outlined above, and the many
others that exist within the broader literature on this
topic, support a role for ROS as signaling molecules. Un-
fortunately, the mechanistic details of these apparent sig-
naling functions remain vague. Further research to
clarify the nature of the ROS-induced protein modifica-
tions, the identity of the affected residues and specificity
of these interactions in various experimental conditions
is necessary to validate the signaling function of ROS in
animal cells. Similarly, it will be essential to understand
the mechanisms by which ROS concentrations are regu-
lated within the cell, and how the systems responsible
for its generation and removal coordinate to support
ROS signaling in complex settings. Once these ROS-
affected pathways have been clearly identified, their
redox-stimulated changes during aging and contribution
to lifespan can be addressed.
Conclusions
The MFRTA has stimulated an enormous amount of re-
search into the role of mitochondrial ROS production and
oxidative stress in aging and longevity. However, as it en-
ters its fifth decade, it seems to be having something of a
mid-life crisis. Virtually all attempts to control mitochon-
drial ROS production or neutralization have yielded unex-
pected and even occasionally unwanted effects on aging
and lifespan. And it seems that those organisms that have
(at least partly) solved the riddle of longevity have notdone so by addressing the ‘ROS problem’. Thus, the
MFRTA has as yet failed to offer a sufficient explanation
of organismal aging as a phenomenon. Methodological
limitations may be invoked to explain the inability to de-
tect the predicted relationships among mitochondrial ROS
production, neutralization, and macromolecule damage
and repair in any specific context. However, it is more dif-
ficult to advance this argument in the context of the many
quite different approaches that have been taken and failed
to consistently validate the predictions. Whether consider-
ing the evolution of longevity by natural selection of spe-
cific traits, the extension of lifespan by caloric restriction,
the ability of transgenes, gene knockouts or small mol-
ecule antioxidants to alter lifespan, the overall conclusion
has been drifting toward ‘no consistent relationship be-
tween mitochondrial ROS and longevity’.
Nonetheless, investigation of the MFRTA has contrib-
uted to the increasing depth of our understanding of ROS
activities in animal cells. ROS are recognized to impinge
upon signaling pathways regulating all of the fundamental
aspects of cell biology: the cell cycle, proliferation and dif-
ferentiation, and life and death (reviewed in [96,97]).
These processes must undoubtedly contribute to the aging
process at some level, but the connection appears far less
direct than that envisioned in the original iteration of the
MFRTA. Going forward, a more nuanced view of the
MFRTA that recognizes the specific properties of individ-
ual ROS, identifies the specific proteins that are redox reg-
ulated, and considers how these ROS interact with specific
cell types and cellular processes may still be productive.
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